| pubmed-article:21123160 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21123160 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:21123160 | lifeskim:mentions | umls-concept:C0014833 | lld:lifeskim |
| pubmed-article:21123160 | lifeskim:mentions | umls-concept:C0006968 | lld:lifeskim |
| pubmed-article:21123160 | lifeskim:mentions | umls-concept:C0016610 | lld:lifeskim |
| pubmed-article:21123160 | lifeskim:mentions | umls-concept:C0268821 | lld:lifeskim |
| pubmed-article:21123160 | lifeskim:mentions | umls-concept:C0231242 | lld:lifeskim |
| pubmed-article:21123160 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:21123160 | pubmed:dateCreated | 2010-12-2 | lld:pubmed |
| pubmed-article:21123160 | pubmed:abstractText | The aim of this observational prospective study was to compare the effect of fosfomycin tromethanol (FT) and carbapenems (meropenem or imipenem cilastatin) in the treatment of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli-related complicated lower urinary tract infection (CLUTI). Inclusion criteria were: patients who were aged >18 yr with dysuria or problems with frequency or urgency in passing urine; those with >20 leukocytes/mm³ in urine microscopy and culture-proven ESBL-producing carbapenem or FT-sensitive E. coli in the urine (>10? cfu/mm³); no leukocytosis or fever; and who were treated with ft (oral 3 g sachet x 1 every other night, three times) or carbapenems between march 2005 and January 2006 in our outpatient clinic and hospital. A total of 47 CLUTI attacks in 47 patients (27 FT group, 20 carbapenem group) were observed prospectively. Clinical and microbiological success in the carbapenem and ft groups was similar (19/20 vs 21/27 and 16/20 vs 16/27 p>0.05). Drug acquisition costs were significantly lower in the FT group (p<0.001). Although it is not a randomized controlled study, these data show that ft may be a suitable, effective and cheap alternative in the treatment of ESBL-producing E. coli-related CLUTI. | lld:pubmed |
| pubmed-article:21123160 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21123160 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21123160 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21123160 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21123160 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21123160 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21123160 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21123160 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21123160 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:21123160 | pubmed:issn | 1973-9478 | lld:pubmed |
| pubmed-article:21123160 | pubmed:author | pubmed-author:UlusoySS | lld:pubmed |
| pubmed-article:21123160 | pubmed:author | pubmed-author:SenolSS | lld:pubmed |
| pubmed-article:21123160 | pubmed:author | pubmed-author:BellJJ3rd | lld:pubmed |
| pubmed-article:21123160 | pubmed:author | pubmed-author:TasbakanMM | lld:pubmed |
| pubmed-article:21123160 | pubmed:author | pubmed-author:YamazhanTT | lld:pubmed |
| pubmed-article:21123160 | pubmed:author | pubmed-author:PullukcuHH | lld:pubmed |
| pubmed-article:21123160 | pubmed:author | pubmed-author:SipahiO ROR | lld:pubmed |
| pubmed-article:21123160 | pubmed:author | pubmed-author:SipahiHH | lld:pubmed |
| pubmed-article:21123160 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21123160 | pubmed:volume | 22 | lld:pubmed |
| pubmed-article:21123160 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21123160 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21123160 | pubmed:pagination | 355-7 | lld:pubmed |
| pubmed-article:21123160 | pubmed:meshHeading | pubmed-meshheading:21123160... | lld:pubmed |
| pubmed-article:21123160 | pubmed:meshHeading | pubmed-meshheading:21123160... | lld:pubmed |
| pubmed-article:21123160 | pubmed:meshHeading | pubmed-meshheading:21123160... | lld:pubmed |
| pubmed-article:21123160 | pubmed:meshHeading | pubmed-meshheading:21123160... | lld:pubmed |
| pubmed-article:21123160 | pubmed:meshHeading | pubmed-meshheading:21123160... | lld:pubmed |
| pubmed-article:21123160 | pubmed:meshHeading | pubmed-meshheading:21123160... | lld:pubmed |
| pubmed-article:21123160 | pubmed:meshHeading | pubmed-meshheading:21123160... | lld:pubmed |
| pubmed-article:21123160 | pubmed:meshHeading | pubmed-meshheading:21123160... | lld:pubmed |
| pubmed-article:21123160 | pubmed:meshHeading | pubmed-meshheading:21123160... | lld:pubmed |
| pubmed-article:21123160 | pubmed:meshHeading | pubmed-meshheading:21123160... | lld:pubmed |
| pubmed-article:21123160 | pubmed:meshHeading | pubmed-meshheading:21123160... | lld:pubmed |
| pubmed-article:21123160 | pubmed:meshHeading | pubmed-meshheading:21123160... | lld:pubmed |
| pubmed-article:21123160 | pubmed:meshHeading | pubmed-meshheading:21123160... | lld:pubmed |
| pubmed-article:21123160 | pubmed:meshHeading | pubmed-meshheading:21123160... | lld:pubmed |
| pubmed-article:21123160 | pubmed:meshHeading | pubmed-meshheading:21123160... | lld:pubmed |
| pubmed-article:21123160 | pubmed:meshHeading | pubmed-meshheading:21123160... | lld:pubmed |
| pubmed-article:21123160 | pubmed:meshHeading | pubmed-meshheading:21123160... | lld:pubmed |
| pubmed-article:21123160 | pubmed:meshHeading | pubmed-meshheading:21123160... | lld:pubmed |
| pubmed-article:21123160 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:21123160 | pubmed:articleTitle | Carbapenem versus fosfomycin tromethanol in the treatment of extended-spectrum beta-lactamase-producing Escherichia coli-related complicated lower urinary tract infection. | lld:pubmed |
| pubmed-article:21123160 | pubmed:affiliation | Celal Bayar University, Department of Infectious Diseases and Clinical Microbiology, Manisa, Turkey. | lld:pubmed |
| pubmed-article:21123160 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21123160 | pubmed:publicationType | Comparative Study | lld:pubmed |
